Phospholane-Catalyzed Wittig Reaction
70 eV): m/z (%) = 218 (100) [M]+, 187 (94) [M+ – OMe], 159 (19) (300 MHz, CDCl3, major isomer): δ = 2.50–2.59 (m, 2 H, CH2),
[M+ – CO2Me], 158 (25), 115 (85), 79 (16).
2.76–2.82 (t, J = 7.7 Hz, 2 H, CH2), 3.74 (s, 3 H, CH3), 5.87 (dt, J
= 15.7 Hz, J = 1.6 Hz, 1 H, CH), 7.03 (dt, J = 15.7 Hz, J = 6.8 Hz,
1 H, CH), 7.17–7.25 (m, 3 H, ArH), 7.27–7.34 (m, 2 H, ArH) ppm.
13C NMR (75 MHz, CDCl3, major isomer): δ = 33.9 (CH2), 34.3
(CH2), 51.4 (CH3), 121.4 (CH), 126.1 (CH), 128.3 (2ϫ CH), 128.5
(2ϫ CH), 140.7 (C), 148.3 (CH), 167.0 (C=O) ppm. MS (EI,
70 eV): m/z (%) = 190 (1) [M]+, 158 (8) [M+ – OMe], 130 (15) [M+ –
CO2Me], 91 (100).
Methyl 3-(Quinolin-2-yl)propenoate (5p): By following GP1, quinol-
ine-2-carbaldehyde (3p, 295 mg, 1.88 mmol), methyl bromoacetate
(4a, 345 mg, 2.26 mmol), 2-phenylisophosphindoline 2-oxide (2,
21 mg, 0.09 mmol), Na2CO3 (299 mg, 2.82 mmol), and HSi(OMe)3
(459 mg, 3.76 mmol) were combined in toluene (3.8 mL). Purifica-
tion by flash chromatography (SiO2; cyclohexane/EtOAc, 10:1) af-
1
forded 5p (90 mg, 22%; E/Z, 95:5) as a yellowish solid. H NMR
Methyl Non-2-enoate (5t): By following GP1, heptanal (3t, 181 mg,
1.59 mmol), methyl bromoacetate (4a, 292 mg, 1.91 mmol), 2-phen-
ylisophosphindoline 2-oxide (2, 18 mg, 0.079 mmol), Na2CO3
(253 mg, 2.39 mmol), and HSi(OMe)3 (389 mg, 3.18 mmol) were
combined in toluene (3.2 mL). Purification by flash chromatog-
raphy (SiO2; cyclohexane/EtOAc, 10:1) afforded 5t (190 mg, 70%;
(300 MHz, CDCl3): δ = 3.86 (s, 3 H, CH3), 7.03 (d, J = 16.0 Hz, 1
H, CH), 7.56–7.60 (m, 1 H, ArH), 7.62–7.64 (m, 1 H, ArH), 7.74–
7.78 (m, 1 H, ArH), 7.82–7.85 (m, 1 H, ArH), 7.93 (d, J = 16.0 Hz,
1 H, CH), 8.13–8.16 (m, 1 H, ArH), 8.20–8.22 (m, 1 H, ArH) ppm.
13C NMR (75 MHz, CDCl3): δ = 51.9 (CH3), 120.3 (CH), 123.2
(CH), 127.3 (CH), 127.5 (CH), 128.0 (C), 129.8 (CH), 130.0 (CH),
136.7 (CH), 144.3 (CH), 148.2 (C), 153.0 (C), 166.9 (C=O) ppm.
MS (EI, 70 eV): m/z (%) = 213 (66) [M]+, 198 (16) [M+ – Me], 182
(85) [M+ – OMe], 155 (100), 154 (80) [M+ – CO2Me], 129 (32), 128
(64), 127 (18), 101 (22), 77 (30).
1
E/Z, 79:21) as a colorless oil. H NMR (300 MHz, CDCl3, major
isomer): δ = 0.86–0.92 (m, 3 H, CH3), 1.24–1.51 (m, 8 H, CH2),
2.16–2.24 (m, 2 H, CH2), 3.73 (s, 3 H, CH3), 5.82 (dt, J = 15.7 Hz,
J = 1.6 Hz, 1 H, CH), 6.98 (dt, J = 15.7 Hz, J = 7.0 Hz, 1 H,
CH) ppm. 13C NMR (75 MHz, CDCl3, major isomer): δ = 14.0
(CH3), 22.5 (CH2), 27.9 (CH2), 28.7 (CH2), 31.5 (CH2), 32.2 (CH2),
51.3 (CH3), 120.7 (CH), 149.5 (CH), 167.1 (C=O) ppm. MS (EI,
Methyl 5-(5-Methylfur-2-yl)hex-2-enoate (5q): By following GP1, 3-
(5-methylfur-2-yl)butanal (3q, 184 mg, 1.21 mmol), methyl bromo-
acetate (4a, 222 mg, 1.45 mmol), 2-phenylisophosphindoline
2-oxide (2, 14 mg, 0.06 mmol), Na2CO3 (296 mg, 1.82 mmol), and
HSi(OMe)3 (296 mg, 2.42 mmol) were combined in toluene
(2.4 mL). Purification by flash chromatography (SiO2; cyclohexane/
EtOAc, 5:1) afforded 5q (185 mg, 73%; E/Z, 79:21) as a yellow oil.
1H NMR (300 MHz, CDCl3, major isomer): δ = 1.25 (d, J =
7.0 Hz, 3 H, CH3), 2.26 (s, 3 H, CH3), 2.33–2.44 (m, 1 H, CH2),
2.55–2.65 (m, 1 H, CH2), 2.89–3.00 (m, 1 H, CH), 3.73 (s, 3 H,
CH3), 5.83–5.88 (m, 3 H, 2 ArH, CH), 6.87–6.97 (m, 1 H,
CH) ppm. 13C NMR (75 MHz, CDCl3, major isomer): δ = 13.4
(CH3), 18.5 (CH3), 32.3 (CH), 38.2 (CH2), 51.3 (CH3), 104.6 (CH),
105.6 (CH), 122.4 (CH), 147.0 (CH), 150.4 (C), 157.0 (C), 166.8
(C=O) ppm. MS (EI, 70 eV): m/z (%) = 208 (4) [M]+, 109 (100)
70 eV): m/z (%) = 139 (34) [M+ – OMe], 138 (32), 113 (37) [M+
–
C4H9], 101 (18), 100 (21), 96 (51), 87 (100), 81 (32), 74 (34), 69
(39), 55 (72).
Methyl Trideca-2,12-dienoate (5u): By following GP1, undec-10-
enal (3u, 249 mg, 1.48 mmol), methyl bromoacetate (4a, 272 mg,
1.78 mmol), 2-phenylisophosphindoline 2-oxide (2, 17 mg,
0.07 mmol), Na2CO3 (235 mg, 2.22 mmol), and HSi(OMe)3
(362 mg, 2.96 mmol) were combined in toluene (3.0 mL). Purifica-
tion by flash chromatography (SiO2; cyclohexane/EtOAc, 10:1) af-
1
forded 5u (220 mg, 66%; E/Z, 80:20) as a colorless oil. H NMR
(300 MHz, CDCl3, major isomer): δ = 1.25–1.50 (m, 12 H, CH2),
2.00–2.09 (m, 2 H, CH2), 2.16–2.24 (m, 2 H, CH2), 3.73 (s, 3 H,
CH3), 4.90–5.04 (m, 2 H, CH2), 5.75–5.89 (m, 2 H, CH), 6.98 (dt,
J = 15.6 Hz, J = 7.0 Hz, 1 H, CH) ppm. 13C NMR (75 MHz,
CDCl3, major isomer): δ = 27.9 (CH2), 28.8 (CH2), 29.0 (CH2),
29.0 (CH2), 29.2 (CH2), 29.3 (CH2), 32.1 (CH2), 33.7 (CH2), 51.2
(CH3), 114.1 (CH), 120.7 (CH), 139.0 (CH), 149.6 (CH), 167.1
(C=O) ppm. MS (EI, 70 eV): m/z (%) = 224 (1) [M]+, 150 (33), 142
(17), 135 (15), 121 (22), 113 (65), 109 (28), 100 (37), 95 (51), 87
(49), 81 (95), 67 (63), 55 (100), 41 (76).
[M+ – C H CO Me]. IR [attenuated total reflectance (ATR)]: ν =
˜
3
4
2
2951 (w), 1721 (vs), 1657 (m), 1613 (w), 1566 (w), 1436 (m), 1270
(m), 1216 (s), 1164 (vs), 1112 (m), 1019 (s), 957 (m), 940 (m), 780
(s), 720 (m) cm–1. HRMS (EI): calcd. for C12H16O3 208.1094; found
208.1090. C12H16O3 (208.26): calcd. C 69.21, H 7.74; found C
69.19, H 7.65.
Methyl 4,4-(Diphenyl)but-2-enoate (5r): By following GP1, di-
phenylacetaldehyde (3r, 330 mg, 1.68 mmol), methyl bromoacetate
(4a, 308 mg, 2.02 mmol), 2-phenylisophosphindoline 2-oxide (2,
19 mg, 0.08 mmol), Na2CO3 (267 mg, 2.52 mmol), and HSi(OMe)3
(411 mg, 3.36 mmol) were combined in toluene (3.3 mL). Purifica-
tion by flash chromatography (SiO2; cyclohexane/EtOAc, 20:1) af-
Methyl 5,7,7-Trimethyloct-2-enoate (5v): By following GP1, 3,5,5-
trimethylhexanal (3v, 213 mg, 1.50 mmol), methyl bromoacetate
(4a, 275 mg, 1.80 mmol), 2-phenylisophosphindoline 2-oxide (2,
17 mg, 0.08 mmol), Na2CO3 (238 mg, 2.25 mmol), and HSi(OMe)3
(367 mg, 3.00 mmol) were combined in toluene (3.0 mL). Purifica-
tion by flash chromatography (SiO2; cyclohexane/EtOAc, 10:1) af-
forded 5v (219 mg, 1.10 mmol, 74%; E/Z, 78:22) as a colorless oil.
1H NMR (300 MHz, CDCl3, major isomer): δ = 0.90 (s, 9 H, 3ϫ
CH3), 0.92–0.97 (m, 3 H, CH3), 1.00–1.31 (m, 2 H, CH2), 1.58–
1.77 (m, 1 H, CH), 2.00–2.32 (m, 2 H, CH2), 3.74 (s, 3 H, CH3),
5.82 (dt, J = 15.5 Hz, J = 1.5 Hz, 1 H, CH), 6.95 (dt, J = 15.6 Hz,
J = 7.5 Hz, 1 H, CH) ppm. 13C NMR (75 MHz, CDCl3, major
isomer): δ = 22.3 (CH3), 28.8 (CH), 29.8 (3ϫ CH3), 30.9 (C), 41.8
(CH2), 50.3 (CH2), 51.1 (CH3), 121.9 (CH), 148.3 (CH), 166.7
1
forded 5r (331 mg, 78%; E/Z, 95:5). H NMR (300 MHz, CDCl3,
major isomer): δ = 3.74 (s, 3 H, CH3), 4.90 (d, J = 7.3 Hz, 1 H,
CH), 5.76 (dd, J = 15.6 Hz, J = 1.5 Hz, 1 H, CH), 7.16–7.36 (m,
10 H, 10 ArH), 7.42–7.52 (m, 1 H, CH) ppm. 13C NMR (75 MHz,
CDCl3, major isomer): δ = 51.4 (CH3), 53.3 (CH), 122.4 (CH),
126.8 (2ϫ CH), 128.5 (4ϫ CH), 128.6 (4ϫ CH), 141.4 (2ϫ C),
150.1 (CH), 166.7 (C=O) ppm. MS (EI, 70 eV): m/z (%) = 252 (14)
[M]+, 221 (15) [M+ – OMe], 193 (93) [M+ – CO2Me], 192 (100),
191 (39), 178 (29), 165 (33), 115 (93), 91 (18).
(C=O) ppm. IR (ATR): ν = 2953 (m), 2905 (m), 2869 (w), 1724
˜
Methyl 5-Phenylpent-2-enoate (5s): By following GP1, 3-phenyl-
propanal (3s, 210 mg, 1.57 mmol), methyl bromoacetate (4a,
288 mg, 1.88 mmol), 2-phenylisophosphindoline 2-oxide (2, 18 mg,
0.08 mmol), Na2CO3 (250 mg, 2.36 mmol), and HSi(OMe)3
(384 mg, 3.14 mmol) were combined in toluene (3.1 mL). Purifica-
tion by flash chromatography (SiO2; cyclohexane/EtOAc, 20:1) af-
(vs), 1657 (m), 1468 (m), 1436 (m), 1395 (w), 1363 (m), 1309 (s),
1270 (w), 1226 (w), 1195 (s), 1162 (s), 1128 (m), 1101 (m), 1043
(m), 982 (s), 921 (m), 816 (m), 718 (m) cm–1. HRMS (EI): calcd.
for C12H22O2 198.1614; found 198.1617.
Methyl 6-(5,5-Dimethyl-1,3-dioxanyl)-hex-2-enoate (5w): By follow-
forded 5s (216 mg, 72%; E/Z, 83:17) as a colorless oil. 1H NMR ing GP1, 4-(5,5-dimethyl-1,3-dioxanyl)butanal (3w, 266 mg,
Eur. J. Org. Chem. 2015, 3286–3295
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3293